Viewing data from:

LIFITEGRAST

ANDA

LIFITEGRAST | A215063 | EUGIA PHARMA SPECIALITIES LTD

1 strength0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Novartis Pharmaceuticals Corporation v. Aurobindo Pharma Ltd. et al 1:2020cv01426 15 patentsANDA 215063lifitegrast	D. Del.	2020-10-23	Terminated 2023-03-27	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain13 active DMFs

12 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDLIFITEGRAST

DMF 336812019

ALIVUS LIFE SCIENCES LTDLIFITEGRAST

DMF 337112019

MSN LIFE SCIENCES PRIVATE LTDLIFITEGRAST

DMF 342802019

OLON SPALIFITEGRAST

DMF 345512020

APITORIA PHARMA PRIVATE LTDLIFITEGRAST

DMF 345762020

SUN PHARMACEUTICAL INDUSTRIES LTDLIFITEGRAST

DMF 347002020

MICRO LABS LTDLIFITEGRAST

DMF 347352020

SCINOPHARM TAIWAN LTDLIFITEGRAST

DMF 354212020

INTERQUIM SALIFITEGRAST

DMF 356522022

OLON SPALIFITEGRAST TYPE II

DMF 372152022

GUANG'AN KINGDAY PHARMA AND CHEM CO LTDLIFITEGRAST

DMF 381792023

VIWIT PHARMACEUTICAL CO LTDLIFITEGRAST

DMF 401722024

HONOUR LAB LTDLIFITEGRAST

DMF 424522025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Nov 7, 2023

No patent or exclusivity listings for this strength.